Mononucleosis Diagnostic Market Segments and Growth by 2031
Mononucleosis Diagnostic Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Monospot Test, Epstein Barr Virus Antibody Test, and Complete Blood Count Test), End User (Hospitals, Laboratories, and Others), and Geography
- Status : Published
- Report Code : TIPRE00019689
- Category : Life Sciences
- No. of Pages : 210
- Available Report Formats :
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is expected to register a CAGR of 4.9% during 2023–2031.
The mononucleosis diagnostic market value is expected to reach US$ 222.15 million by 2031.
Advancements in molecular diagnostics are likely to bring new growth trends in the market in the coming years.
Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc., Launch Diagnostics Ltd, Biorex Diagnostics, and ZEUS Scientific are among the key players operating in the market.
The high risk among the adolescent population, and the rising health awareness and knowledge about mononucleosis are among the most significant factors fueling the market growth.
North America dominated the market in 2023.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Mononucleosis Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Mononucleosis Diagnostics Market – Key Market Dynamics
5.1 Mononucleosis Diagnostics Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 High Risk among Adolescent Population
5.2.2 Rising Health Awareness and Knowledge About Mononucleosis
5.3 Market Restraints
5.3.1 Low Accuracy of Existing Diagnostic Tests
5.4 Market Opportunities
5.4.1 Development of Point-of-Care Testing
5.5 Future Trends
5.5.1 Advancements in Molecular Diagnostics
5.6 Impact of Drivers and Restraints:
6. Mononucleosis Diagnostics Market – Global Market Analysis
6.1 Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021–2031
6.2 Mononucleosis Diagnostics Market Forecast Analysis
7. Mononucleosis Diagnostics Market Analysis – by Type
7.1 Monospot Test
7.1.1 Overview
7.1.2 Monospot Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
7.2 Epstein Barr Virus Antibody Test
7.2.1 Overview
7.2.2 Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
7.3 Complete Blood Count Test
7.3.1 Overview
7.3.2 Complete Blood Count Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
8. Mononucleosis Diagnostics Market Analysis – by End User
8.1 Hospital
8.1.1 Overview
8.1.2 Hospital: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
8.2 Laboratories
8.2.1 Overview
8.2.2 Laboratories: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
8.3 Others
8.3.1 Overview
8.3.2 Others: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9. Mononucleosis Diagnostics Market – Geographical Analysis
9.1 North America
9.1.1 North America Mononucleosis Diagnostics Market Overview
9.1.2 North America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.3 North America: Mononucleosis Diagnostics Market Breakdown, by Type
9.1.3.1 North America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.1.4 North America: Mononucleosis Diagnostics Market Breakdown, by End User
9.1.4.1 North America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.1.5 North America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.1.5.1 United States: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.5.1.1 United States: Mononucleosis Diagnostics Market Breakdown, by Type
9.1.5.1.2 United States: Mononucleosis Diagnostics Market Breakdown, by End User
9.1.5.2 Canada: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.5.2.1 Canada: Mononucleosis Diagnostics Market Breakdown, by Type
9.1.5.2.2 Canada: Mononucleosis Diagnostics Market Breakdown, by End User
9.1.5.3 Mexico: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.1.5.3.1 Mexico: Mononucleosis Diagnostics Market Breakdown, by Type
9.1.5.3.2 Mexico: Mononucleosis Diagnostics Market Breakdown, by End User
9.2 Europe
9.2.1 Europe Mononucleosis Diagnostics Market Overview
9.2.2 Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.2.1 Europe: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.2.2.2 Europe: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.2.3 Europe: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.2.3.1 Germany: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.1.1 Germany: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.1.2 Germany: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.2 United Kingdom: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.2.1 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.2.2 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.3 France: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.3.1 France: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.3.2 France: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.4 Italy: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.4.1 Italy: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.4.2 Italy: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.5 Spain: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.5.1 Spain: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.5.2 Spain: Mononucleosis Diagnostics Market Breakdown, by End User
9.2.3.6 Rest of Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.2.3.6.1 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by Type
9.2.3.6.2 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by End User
9.3 Asia Pacific
9.3.1 Asia Pacific Mononucleosis Diagnostics Market Overview
9.3.2 Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.2.1 Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.3.2.2 Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.3.3 Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.3.3.1 China: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.1.1 China: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.1.2 China: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.2 Japan: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.2.1 Japan: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.2.2 Japan: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.3 India: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.3.1 India: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.3.2 India: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.4 Australia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.4.1 Australia: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.4.2 Australia: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.5 South Korea: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.5.1 South Korea: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.5.2 South Korea: Mononucleosis Diagnostics Market Breakdown, by End User
9.3.3.6 Rest of APAC: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.3.3.6.1 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by Type
9.3.3.6.2 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by End User
9.4 South and Central America
9.4.1 South and Central America Mononucleosis Diagnostics Market Overview
9.4.2 South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.2.1 South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.4.2.2 South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.4.3 South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.4.3.1 Brazil: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.1.1 Brazil: Mononucleosis Diagnostics Market Breakdown, by Type
9.4.3.1.2 Brazil: Mononucleosis Diagnostics Market Breakdown, by End User
9.4.3.2 Argentina: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.2.1 Argentina: Mononucleosis Diagnostics Market Breakdown, by Type
9.4.3.2.2 Argentina: Mononucleosis Diagnostics Market Breakdown, by End User
9.4.3.3 Rest of South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.4.3.3.1 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by Type
9.4.3.3.2 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by End User
9.5 Middle East and Africa
9.5.1 Middle East and Africa Mononucleosis Diagnostics Market Overview
9.5.2 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.2.1 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Type
9.5.2.2 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by End User
9.5.3 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.5.3.1 Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast Analysis – by Country
9.5.3.2 Saudi Arabia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.2.1 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by Type
9.5.3.2.2 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by End User
9.5.3.3 South Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.3.1 South Africa: Mononucleosis Diagnostics Market Breakdown, by Type
9.5.3.3.2 South Africa: Mononucleosis Diagnostics Market Breakdown, by End User
9.5.3.4 United Arab Emirates: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.4.1 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by Type
9.5.3.4.2 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by End User
9.5.3.5 Rest of Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
9.5.3.5.1 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Type
9.5.3.5.2 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by End User
10. Industry Landscape
10.1 Overview
10.2 Growth Strategies in Mononucleosis Diagnostic Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Abbott Laboratories
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Arlington Scientific Inc
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Bio-Rad Laboratories Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Cardinal Health Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Meridian Bioscience Inc
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Sekisui Diagnostics LLC
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Thermo Fisher Scientific Inc
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 QuidelOrtho Corp
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 F. Hoffmann-La Roche Ltd
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 QIAGEN NV
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Hologic Inc
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 bioMerieux SA
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Products and Services
11.12.4 Financial Overview
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 DiaSorin SpA
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Products and Services
11.13.4 Financial Overview
11.13.5 SWOT Analysis
11.13.6 Key Developments
11.14 Immunostics Inc.
11.14.1 Key Facts
11.14.2 Business Description
11.14.3 Products and Services
11.14.4 Financial Overview
11.14.5 SWOT Analysis
11.14.6 Key Developments
11.15 Launch Diagnostics Ltd
11.15.1 Key Facts
11.15.2 Business Description
11.15.3 Products and Services
11.15.4 Financial Overview
11.15.5 SWOT Analysis
11.15.6 Key Developments
11.16 Biorex Diagnostics
11.16.1 Key Facts
11.16.2 Business Description
11.16.3 Products and Services
11.16.4 Financial Overview
11.16.5 SWOT Analysis
11.16.6 Key Developments
11.17 ZEUS Scientific
11.17.1 Key Facts
11.17.2 Business Description
11.17.3 Products and Services
11.17.4 Financial Overview
11.17.5 SWOT Analysis
11.17.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms for Mononucleosis Diagnostics Market
List of Tables
Table 1. Mononucleosis Diagnostics Market Segmentation
Table 2. North America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 3. North America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 4. United States: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 5. United States: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 6. Canada: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 7. Canada: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 8. Mexico: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 9. Mexico: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 10. Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 11. Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 12. Germany: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 13. Germany: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 14. United Kingdom: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 15. United Kingdom: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 16. France: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 17. France: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 18. Italy: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 19. Italy: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 20. Spain: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 21. Spain: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 22. Rest of Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 23. Rest of Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 24. Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 25. Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 26. China: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 27. China: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 28. Japan: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 29. Japan: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 30. India: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 31. India: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 32. Australia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 33. Australia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 34. South Korea: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 35. South Korea: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 36. Rest of APAC: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 37. Rest of APAC: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 38. South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 39. South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 40. Brazil: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 41. Brazil: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 42. Argentina: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 43. Argentina: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 44. Rest of South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 45. Rest of South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 46. Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 47. Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 48. Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Country
Table 49. Saudi Arabia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 50. Saudi Arabia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 51. South Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 52. South Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 53. United Arab Emirates: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 54. United Arab Emirates: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 55. Rest of Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by Type
Table 56. Rest of Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand) – by End User
Table 57. Recent Organic Growth Strategies in Mononucleosis Diagnostic Market
Table 58. Recent Inorganic Growth Strategies in the Mononucleosis Diagnostic Market
Table 59. Glossary of Terms
List of Figures
Figure 1. Mononucleosis Diagnostics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021–2031
Figure 5. Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 6. Mononucleosis Diagnostics Market Share (%) – by Type (2023 and 2031)
Figure 7. Monospot Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 8. Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 9. Complete Blood Count Test: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 10. Mononucleosis Diagnostics Market Share (%) – by End User (2023 and 2031)
Figure 11. Hospital: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 12. Laboratories: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. Others: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031 (US$ Thousand)
Figure 14. North America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 15. North America: Mononucleosis Diagnostics Market Breakdown, by Type (2023 and 2031)
Figure 16. North America: Mononucleosis Diagnostics Market Breakdown, by End User (2023 and 2031)
Figure 17. North America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. United States: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 19. Canada: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 20. Mexico: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 21. Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 22. Europe: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. Germany: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 24. United Kingdom: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 25. France: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 26. Italy: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 27. Spain: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 28. Rest of Europe: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 29. Asia Pacific: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 30. Asia Pacific: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. China: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 32. Japan: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 33. India: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 34. Australia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 35. South Korea: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 36. Rest of APAC: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 37. South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 38. South and Central America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 39. Brazil: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 40. Argentina: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 41. Rest of South and Central America: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 42. Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 43. Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 44. Saudi Arabia: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 45. South Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 46. United Arab Emirates: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 47. Rest of Middle East and Africa: Mononucleosis Diagnostics Market – Revenue and Forecast to 2031(US$ Thousand)
Figure 48. Growth Strategies in Mononucleosis Diagnostic Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For